SLXN
NASD Silexion Therapeutics Corp$0.2484 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2484, $0.0276 below the day’s high of $0.2760
- YTD change
- -98.71%
- vs 20-day SMA
- -31.77%
- vs 200-day SMA
- -97.41%
Price ranges
Price & Performance
-0.91 (-78.59%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $6,277.5000
- SLXN is down 99% since the beginning of the year
- SLXN is down 99% over the past 12 months
- SLXN is down 31% over the past 1 month
- 0% of all SLXN investors are betting against SLXN
SLXN reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -92.7%.
- Previous minute
- +$0.0034
- Last hour
- +$0.0165
- Last 5 days
- -42.96%
- vs 8-day SMA
- -32.05%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.